New Zealand markets close in 48 minutes

Vyant Bio, Inc. (1C80.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.23200.0000 (0.00%)
At close: 08:02AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-43,277
-22,690
-40,859
-8,650
Depreciation & amortisation
1,078
843
1,054
1,110
Stock-based compensation
1,043
1,186
1,003
372
Change in working capital
1,038
891
-2,687
1,329
Inventory
415
422
-60
-43
Accounts payable
313
-85
-1,146
878
Other working capital
-14,014
-14,298
-17,528
-5,872
Other non-cash items
26,892
6,882
24,961
264
Net cash provided by operating activities
-13,392
-13,681
-16,993
-5,812
Cash flows from investing activities
Investments in property, plant and equipment
-622
-617
-535
-60
Net cash used for investing activities
-757
3,263
29,619
-43
Cash flows from financing activities
Debt repayment
-168
-191
-119
-76
Common stock issued
-
-
41
98
Common stock repurchased
-188
-188
-
-
Net cash used provided by (used for) financing activities
381
-113
7,222
6,332
Net change in cash
-13,809
-10,567
19,816
477
Cash at beginning of period
23,203
20,608
792
315
Cash at end of period
9,394
10,041
20,608
792
Free cash flow
Operating cash flow
-13,392
-13,681
-16,993
-5,812
Capital expenditure
-622
-617
-535
-60
Free cash flow
-14,014
-14,298
-17,528
-5,872